DZ2576A1 - Compositions parentérales d'alatrofloxacine. - Google Patents

Compositions parentérales d'alatrofloxacine.

Info

Publication number
DZ2576A1
DZ2576A1 DZ980186A DZ980186A DZ2576A1 DZ 2576 A1 DZ2576 A1 DZ 2576A1 DZ 980186 A DZ980186 A DZ 980186A DZ 980186 A DZ980186 A DZ 980186A DZ 2576 A1 DZ2576 A1 DZ 2576A1
Authority
DZ
Algeria
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
Prior art date
Application number
DZ980186A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2576A1 publication Critical patent/DZ2576A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ980186A 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine. DZ2576A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
DZ2576A1 true DZ2576A1 (fr) 2003-02-22

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980186A DZ2576A1 (fr) 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine.

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230030B1 (hu) * 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
EP1560584B1 (fr) 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
EP1575951B1 (fr) * 2002-12-06 2014-06-25 Debiopharm International SA Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
WO2004082586A2 (fr) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (fr) 2007-02-16 2014-08-20 Debiopharm Int Sa Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
JP6702883B2 (ja) * 2014-04-25 2020-06-03 ノーレックス インコーポレイテッド 向神経活性ペプチドの安定な組成物
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (fr) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Formes cristallines de dimères de dexaméthasone et leurs utilisations
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
WO2021220061A2 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions hétérodimères et méthodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DK0789697T3 (da) 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
DE69622715T2 (de) * 1995-06-15 2002-11-14 Pfizer Inc., New York Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin-carbonsäure
US6080756A (en) * 1995-08-29 2000-06-27 Pfizer Inc. Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
WO1997007800A1 (fr) 1995-08-29 1997-03-06 Pfizer Inc. Formes zwitterioniques de trovafloxacine
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
PT1000086E (pt) 2004-05-31
MA24626A1 (fr) 1999-04-01
BG104105A (bg) 2000-08-31
HUP0004793A2 (hu) 2001-04-28
DE69821767T2 (de) 2005-01-13
JP3463928B2 (ja) 2003-11-05
CN1265671A (zh) 2000-09-06
JP2001512133A (ja) 2001-08-21
DE69821767D1 (de) 2004-03-25
HRP980417B1 (en) 2002-10-31
HRP980417A2 (en) 1999-08-31
HUP0004793A3 (en) 2001-10-29
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
BR9811580A (pt) 2000-08-22
UY25113A1 (es) 2000-12-29
NO20000485D0 (no) 2000-01-31
ATE259827T1 (de) 2004-03-15
NZ502249A (en) 2001-11-30
EP1000086A1 (fr) 2000-05-17
AR015417A1 (es) 2001-05-02
CO4970688A1 (es) 2000-11-07
HN1998000106A (es) 1999-01-08
AU734863B2 (en) 2001-06-21
SK1012000A3 (en) 2000-09-12
CA2296466A1 (fr) 1999-02-11
ZA986874B (en) 2000-01-31
KR20010022495A (ko) 2001-03-15
AU8236898A (en) 1999-02-22
OA11281A (en) 2002-11-19
YU2500A (sh) 2002-09-19
ES2214716T3 (es) 2004-09-16
WO1999006430A1 (fr) 1999-02-11
EP1000086B1 (fr) 2004-02-18
DK1000086T3 (da) 2004-05-17
IL134156A0 (en) 2001-04-30
EA200000086A1 (ru) 2000-08-28
AP9801310A0 (en) 1998-09-30
NO20000485L (no) 2000-03-27
PE103799A1 (es) 1999-10-25
TNSN98146A1 (fr) 2005-03-15
AP1031A (en) 2001-12-21
GT199800112A (es) 2000-01-15
IS5339A (is) 2000-01-14
ID24374A (id) 2000-07-13
US6194429B1 (en) 2001-02-27
CA2296466C (fr) 2003-04-15
EA002120B1 (ru) 2001-12-24
PA8456701A1 (es) 2000-05-24

Similar Documents

Publication Publication Date Title
DZ2576A1 (fr) Compositions parentérales d'alatrofloxacine.
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
FI974241A7 (fi) BPM-15 -koostumukset
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
NO980290L (no) 2(4-substituert)benzylamino-2-metylpropanamidderivater
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ID19801A (id) Turunan-turunan 5'-deoksi-sitidina
ITMI941407A0 (it) Composizioni cementizie mdf con migliorata tenacita'
PL340372A1 (en) Novel 3,6x-hemiketals of 9a-azalydes class
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
EE9800168A (et) Tahked kompositsioonid
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
IT1272346B (it) "accessorio di raccordo".
MA26481A1 (fr) Derives d'arylsecocholadiene
FR2710673B1 (fr) Composition d'enduit de parement.
IT1293525B1 (it) Bis-acridincarbossiammidi aventi attivita' antitumorale
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
UA1629S (uk) Набір фестонів "веснянка-5"
UA2139S (uk) Обкладинка телефонного довідника "жовті сторінки"
UA1914S (uk) Крекер "фірмовий"
ITCS970006V0 (it) "1 m"
UA1916S (uk) Крекер "оригінальний"
ES1038172Y (es) "caja-contenedor".